ExpressionEdits

ExpressionEdits is a biotechnology company developing computational tools to improve protein expression from artificial gene constructs.

Its Genetic Syntax Engine uses machine learning and biological data to predict optimal intron insertion patterns within transgenes, increasing protein production levels in mammalian systems. The platform has applications across gene therapy, biologics development and recombinant protein manufacturing.

The company is a spin-out from the University of Cambridge and has a collaboration with Boehringer Ingelheim.